Reagent recycling scheme acknowledges ‘green’ companies
Hach Lange presents two UK customers with silver bars made from recycled chemical test reagents
Scottish Water and NWL Scientific Services have received silver bars made from recycled test reagents from the firm, which encourages its customers to recycle these products.
Hach Lange has a recycling centre in Germany, which facilitates recovery of toxic materials from reagent tubes, including chemical oxygen demand (COD) cuvettes from which mercury, silver and chromium are recovered. Over 70% of returned materials are either re-used or recycled.
Paul Burton, environmental laboratory manager at NWL Scientific Services, said: ‘As a company we recycle as much as we possibly can and ensure that all used reagents are disposed of as ethically as possible. This is why we fully support Hach Lange’s recycling initiative and gratefully receive the award for our own efforts.’
David McMullan of Scottish Water added: ‘It is a key company ethic of ours to be as environmentally friendly as possible and so it was a natural choice to become involved in Hach Lange’s scheme for recycled COD reagents. We are very pleased to have received this award and would urge other firms within the water industry to adopt similar recycling policies.’
Thousands of cuvette tests are used every day to analyse the contents of liquids in industries such as water, wastewater, manufacturing, food, beverage and power. Hach Lange says its recycling service helps companies comply with waste management regulations and improve environmental performance.
The company was recently commended at The German Sustainability Awards in the Most Sustainable Products and Supply of Services category.
You may also like
Manufacturing
etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage
etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
From bespoke to scalable: closing the manufacturing gap in advanced therapeutics
Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Manufacturing
Piramal Pharma Solutions announces partnership with Botanix to support drug substance development
Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra. Sofdra is the first and only FDA-approved new chemical entity (NCE) for the treatment of primary axillary hyperhidrosis. Through this partnership, Piramal Pharma Solutions will leverage the strength of its North American drug substance facilities to support robust, consistent patient access to Sofdra
Manufacturing
ProtaGene and Merck partner to deliver end-to-end biologics testing
The duo will combine ProtaGene's early-stage biologics expertise with Merck's BioReliance GMP testing infrastructure, offering biopharmaceutical customers an integrated testing solution across the full drug development lifecycle